European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
Journal of Neuroendocrinology · 2024-09 · 36 (9)
DOI: 10.1111/jne.13423 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 08.07.2024. Verfasst von Angela Lamarca und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology - Onco Health Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Intestinal Neoplasms, Intestine, Small. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 135 Literaturangaben.
Abstract (Originalsprache)
Both the incidence and prevalence of well‐differentiated neuroendocrine tumours from the small intestine (Si‐NET) are gradually increasing. Most patients have non‐functioning tumours with subtle GI symptoms and tumours are often discovered incidentally by endoscopy or at advanced disease stages by imaging depicting mesenteric lymph node and /or liver metastases while around 30% of the patients present with symptoms of the carcinoid syndrome. Adequate biochemical assessment and staging including functional imaging is crucial for treatment‐related decision‐making that should take place in an expert multidisciplinary team setting. Preferably, patients should be referred to specialised ENETS Centres of Excellence or centres of high expertise in the field. This guidance paper provides the current evidence and best knowledge for the management of Si‐NET grade (G) 1–3 following 10 key questions of practical relevance for the diagnostic and therapeutic decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology - Onco Health Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
- Department of Medical Oncology, The Christie NHS Foundation, Manchester, Division of Cancer Sciences, University of Manchester, Manchester, UK.
- Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
- Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK.
- Department of Endocrinology and Neuroendocrine Tumors, ENETS Center of Excellence, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
- Department of Clinical Physiology and Nuclear Medicine and Cluster for Molecular Imaging, Copenhagen University of Copenhagen-Rigshospitalet, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denm…
ORCID-Profile: Angela Lamarca, Beata Kos-Kudla, Anja Rinke, Marie-Louise F van Velthuysen
Zitieren
APA
Lamarca, A., Bartsch, D. K., Caplin, M., Kos-Kudla, B., Kjaer, A., Partelli, S., Rinke, A., Janson, E. T., Thirlwell, C., van Velthuysen, M. F., Vullierme, M. P., & Pavel, M. (2024). European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours. Journal of Neuroendocrinology, 36(9). https://doi.org/10.1111/jne.13423
Vancouver
Lamarca A, Bartsch DK, Caplin M, Kos-Kudla B, Kjaer A, Partelli S, et al. European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours. Journal of Neuroendocrinology. 2024;36(9). doi:10.1111/jne.13423
BibTeX
@article{Lamarca2024,
author = {Lamarca, Angela and Bartsch, Detlef K and Caplin, Martyn and Kos-Kudla, Beata and Kjaer, Andreas and Partelli, Stefano and Rinke, Anja and Janson, Eva Tiensuu and Thirlwell, Christina and van Velthuysen, Marie-Louise F and Vullierme, Marie-Pierre and Pavel, Marianne},
title = {European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours},
journal = {Journal of Neuroendocrinology},
year = {2024},
volume = {36},
number = {9},
doi = {10.1111/jne.13423}
}
EUVIMED